BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35941978)

  • 1. Effects of Autophagy-Related Genes on the Prognosis and Immune Microenvironment of Ovarian Cancer.
    Zhang J; Yan H; Fu Y
    Biomed Res Int; 2022; 2022():6609195. PubMed ID: 35941978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
    Song Y; Qu H
    BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.
    Zhou Q; Chen X; Chen Q; Liu H; Hao L
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a prognostic signature of autophagy-related lncRNAs in non-small-cell lung cancer.
    Zhang X; Cao Y; Chen L
    BMC Cancer; 2021 Aug; 21(1):921. PubMed ID: 34391383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
    Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
    Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
    Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
    [No Abstract]   [Full Text] [Related]  

  • 11. A Novel Autophagy-Related lncRNA Gene Signature to Improve the Prognosis of Patients with Melanoma.
    Ding Y; Li T; Li M; Tayier T; Zhang M; Chen L; Feng S
    Biomed Res Int; 2021; 2021():8848227. PubMed ID: 34250091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer.
    Jin X; Chen Y; Hu Q
    Sci Rep; 2024 Mar; 14(1):7593. PubMed ID: 38556590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy-related long non-coding RNA signature for ovarian cancer.
    Meng C; Zhou JQ; Liao YS
    J Int Med Res; 2020 Nov; 48(11):300060520970761. PubMed ID: 33179541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
    Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
    Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrated Autophagy-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial Cancer: A Bioinformatics-Based Approach.
    Wang Z; Zhang J; Liu Y; Zhao R; Zhou X; Wang H
    Biomed Res Int; 2020; 2020():5717498. PubMed ID: 33381557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
    Front Immunol; 2021; 12():806189. PubMed ID: 35095893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MEG8/miR-378d/SOBP axis as a novel regulatory network and associated with immune infiltrates in ovarian carcinoma by integrated bioinformatics analysis.
    Lei J; He ZY; Wang J; Hu M; Zhou P; Lian CL; Hua L; Wu SG; Zhou J
    Cancer Med; 2021 Apr; 10(8):2924-2939. PubMed ID: 33742531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an N6-methyladenosine lncRNA- and immune cell infiltration-related prognostic model in colorectal cancer.
    Yu ZL; Zhu ZM
    Protoplasma; 2022 Jul; 259(4):1029-1045. PubMed ID: 34734333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seven autophagy-related lncRNAs are associated with the tumor immune microenvironment in predicting survival risk of nonsmall cell lung cancer.
    Jiang H; Xu A; Li M; Han R; Wang E; Wu D; Fei G; Zhou S; Wang R
    Brief Funct Genomics; 2022 May; 21(3):177-187. PubMed ID: 34849558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Five Immune-Related lncRNAs Predicting Survival and Tumor Microenvironment Characteristics in Breast Cancer.
    Xiao R; Yang M; Tan Y; Ding R; Li D
    Comput Math Methods Med; 2021; 2021():6676692. PubMed ID: 33727952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.